We are still excepting deals for our Jan. 21st Investor Network Night and welcome referrals. Investor Network Nights provide a wide range of investment for accredited investors, Self Direct IRAs, Corporations, and other investors. Should the deal not fit Red Hook Capital goal of having $4+ million EBITDA, Investor Network Nights provide great deals a good option for funding.
Here are few deals that closed:
BuzzFeed, a New York-based social publisher, has raised $19.3 million in Series D funding. New Enterprise Associates led the round, and was joined by return backers RRE Ventures, Hearst Interactive, Softbank Capital and Lerer Ventures. Also participating as new investors were Buddy Media co-founders Michael and Kass Lazerow. Visit www.buzzfeed.com or read more at: http://www.bloomberg.com/news/2013-01-03/buzzfeed-raises-19-3-million-in-funding.html
Crescendo Bioscience, a South San Francisco, Calif.-based developer of quantitative blood tests for rheumatoid arthritis and other auto-immune diseases, has raised $28 million in Series D funding. Skyline Ventures and Safeguard Scientifics co-led the round, and were joined by return backers Mohr Davidow Ventures, Kleiner Perkins Caufield & Byers and Aeris Capital. Ferghana Partners served as placement agent. Visit www.CrescendoBio.com or read more at: http://pevc.dowjones.com/article?an=DJFVW00020130103e913any21&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020130103e913any21%26from%3dalert%26pid%3d32
eZono AG, a German developer of portable tablet ultrasound systems, has raised $10 million in VC funding led by MVM Life Science Partners. Visit www.ezono.com or read more at: http://www.finsmes.com/2013/01/ezono-raises-10m-funding.html
Heart Metabolics Ltd., a London-based developer of drugs for the treatment of heart failure symptoms in patients with hypertrophic cardiomyopathy, has raised $4 million in its first tranche of Series A funding. Backers include the Trans Tasman Commercialisation Fund (Australia) and AshHill Investments (Kentucky). Visit www.heartmetabolics.com or read more at: http://www.thestreet.com/story/11803336/1/heart-metabolics-receives-funding-for-us-clinical-development-of-heart-failure-drug.html
Leap Motion, a San Francisco-based provider of motion-control software and hardware, has raised $30 million in new VC funding from return backers Founders Fund and Highland Capital Partners. Visit www.leapmotion.com or read more: http://techcrunch.com/2013/01/03/leap-motion-series-b-plus-asus/
Pluralsight, a Layton, Utah-based provider of online education for software developers, has raised $27.5 million from Insight Venture Partners. This represents the first round of outside capital for Pluralsight, which was founded in 2004. Visit www.pluralsight.com or read more at: http://allthingsd.com/20130103/education-site-pluralsight-raises-first-outside-funding-ever-27-5m/
Remitly, a Seattle-based provider of online money transfer solutions, has raised $2.6 million in new VC funding. Trilogy Equity Partners led the round, and was joined by Bezos Expeditions and TomorrowVentures. Visit www.remitly.com or read more at: http://www.geekwire.com/2012/helping-immigrants-send-money-home-jeff-bezosbacked-remitly-lands-26-million/
Happy Networking and Investing,
JD Morris
You must be logged in to post a comment.